Helen Louise Collins Five Prime Therapeutics, Inc. (FPRX) insider trading activity

Helen Louise Collins is EVP and Chief Medical Officer of FIVE PRIME THERAPEUTICS, INC.. Currently has a direct ownership of 0 shares of FPRX, which is worth approximately $0. The most recent transaction as insider was on Apr 16, 2021, when has been sold 135,547 shares (Common Stock) at a price of $38.0 per share, resulting in proceeds of $5,150,786. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

Helen Louise Collins Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 16 2021	SELL Sale (or disposition) back to the issuer	$5,150,786 $38.0 p/Share	135,547 Reduced 100.0%	0 Common Stock
Apr 16 2021	BUY Grant, award, or other acquisition	-	66,000 Added 32.75%	135,547 Common Stock
Mar 31 2021	SELL Bona fide gift	-	8,085 Reduced 10.41%	69,547 Common Stock
Feb 26 2021	SELL Payment of exercise price or tax liability	$25,742 $22.23 p/Share	1,158 Reduced 1.47%	77,632 Common Stock
Feb 25 2021	SELL Payment of exercise price or tax liability	$38,151 $23.08 p/Share	1,653 Reduced 2.05%	78,790 Common Stock
Feb 24 2021	SELL Payment of exercise price or tax liability	$130,890 $25.71 p/Share	5,091 Reduced 5.95%	80,443 Common Stock
Dec 11 2020	SELL Payment of exercise price or tax liability	$186,950 $16.14 p/Share	11,583 Reduced 11.93%	85,534 Common Stock
Dec 11 2020	BUY Exercise of conversion of derivative security	-	22,000 Added 18.47%	97,117 Common Stock
Nov 11 2020	SELL Payment of exercise price or tax liability	$198,702 $18.0 p/Share	11,039 Reduced 12.81%	75,117 Common Stock
Nov 11 2020	BUY Exercise of conversion of derivative security	-	22,000 Added 20.34%	86,156 Common Stock

Also insider at

KURA

Kura Oncology, Inc. Healthcare

IMRA

IMARA Inc. Healthcare

CHIEF MEDICAL OFFICER

IOBT

IO Biotech, Inc. Healthcare

HLC